Semaglutide and other GLP-1 drugs not linked to risk of degenerative eye disease in adults with type 2 diabetes

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of medication that mimics the GLP-1 hormone—to lower blood sugar and support weight loss.

Some research has suggested that their use can reduce the risk of developing other diseases. ...